Preliminary results from two independent, phase II clinical trials investigating a new PD-1 (programmed cell death protein 1)-based immune therapy
Read more
bestallergymedicinehq.org
Home »
Preliminary results from two independent, phase II clinical trials investigating a new PD-1 (programmed cell death protein 1)-based immune therapy
Read moreE-cigarettes are now the most popular product used for smoking cessation in the United States, ahead of all U.S. Food
Read moreScientists have identified nearly 400 established medical practices that have been found to be ineffective by clinical studies published across
Read moreA pair of studies have found that Obamacare led to an increase in early-stage ovarian cancer detections and helped nearly
Read moreThe results of two new Regenstrief Institute trials published in the Journal of the American Geriatrics Society underscore and confirm
Read moreFast and easy blood pressure monitoring could soon be at your fingertips—literally—thanks to new University of British Columbia research that
Read moreTaking fish oil or vitamin D? Big studies give long-awaited answers on who does and does not benefit from these
Read moreExcessive stress during fetal development or early childhood can have long-term consequences for the brain, from increasing the likelihood of
Read more